Market Cap | ₹2,435Cr |
ROE | 0.77% |
P/E Ratio(TTM) | 340.25 |
EPS(TTM) | 3.06 |
P/B Ratio | 3.30 |
Dividend Yield | 0.10% |
Industry P/E | 43.76 |
Book Value | 315.84 |
Debt to Equity | 0.05 |
Face Value | 10 |
Parent Organisation | Tatva Chintan Pharma Chem |
Managing Director | Mr. Chintan Shah |
NSE Symbol | TATVA |
FUND NAME | AUM(%) |
---|---|
Nippon India ELSS Tax Saver Fund Direct Growth | 0.40% |
ICICI Prudential Smallcap Fund Direct Plan Growth | 0.12% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Foseco India | NA (0.00%) | 44.02 | ||
Fineotex Chemical | NA (0.00%) | 27.49 | ||
Paushak | NA (0.00%) | 46.32 | ||
Platinum Industries | NA (0.00%) | 36.09 |